VitaNova Life Sciences (VNOV) Share-based Compensation (2024 - 2026)
VitaNova Life Sciences' (VNOV) quarterly Share-based Compensation came in at $179400.0 in Q2 2026, up 35780.0% on a QoQ basis from $500.0 in Q1 2025.
VitaNova Life Sciences (VNOV) Share-based Compensation (2024 - 2026) Analysis & Trends
VitaNova Life Sciences (VNOV) has 3 years of Share-based Compensation data on file, last reported at $179400.0 in Q2 2026.
- Quarterly Share-based Compensation changed N/A year-over-year to $179400.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $179400.0 (up 8870.0% YoY) and the FY2026 annual result came in at $179400.0, up 8870.0% from the prior year.
- Share-based Compensation improved to $179400.0 in Q2 2026, from $500.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $179400.0 in Q2 2026 to a low of $500.0 in Q1 2025.
- A 3-year average of $36480.0 and a median of $750.0 in 2024 frame the typical range for Share-based Compensation.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.12 Bn | 96.96 Bn | 3.69 Bn | - |
| 2 | Cencora | 61.67 Bn | 58.86 Bn | 3.61 Bn | 17.60 Mn |
| 3 | Cardinal Health | 54.51 Bn | 49.66 Bn | 2.56 Bn | 58.00 Mn |
| 4 | Henry Schein | 10.04 Bn | 9.88 Bn | 1.10 Bn | 7.00 Mn |
| 5 | Akso Health | 820.26 Mn | 820.04 Mn | - | - |
| 6 | Edap Tms | 157.38 Mn | 135.84 Mn | 7.34 Mn | 855,000.00 |
| 7 | Accendra Health | 95.10 Mn | 87.45 Mn | 263.41 Mn | 3.15 Mn |
| 8 | 111 | 30.87 Mn | 109.39 Mn | 18.18 Mn | - |
| 9 | Cosmos Health | 13.30 Mn | 10.86 Mn | 1.51 Mn | 558,858.00 |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 179,400.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 179,400.00 |
| Apr 30, 2026 | 179,400.00 |
| Jan 31, 2025 | 500.00 |
| Jan 31, 2025 | 500.00 |
| Oct 31, 2024 | 750.00 |
| Oct 31, 2024 | 750.00 |
| Jul 31, 2024 | 750.00 |
| Jul 31, 2024 | 750.00 |
| Apr 30, 2024 | 1,000.00 |
| Apr 30, 2024 | 1,000.00 |